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Key messages
What is already known about this subject?
 ► the interaction between  human leucocyte antigen 
(Hla)-e and the inhibitory (cD94/nKg2a) and ac-
tivating (cD94/nKg2c) receptors balances the  re-
sponse of natural killer (nK) cells and cytotoxic t 
lymphocytes.
 ► Hla-e plays a double role in both innate and adap-
tive immunity.
What does this study add?
 ► We report the  upregulation of Hla-e in  ankylos-
ing  spondylitis  immune cells, which may protect 
autoreactive clones from nK cell lysis and there-
fore contribute to the chronicity of the inflammatory 
process.
How might this impact on clinical practice?
 ► Modulation of accessory ligand/receptor pairs may 
affect disease course and contribute to inhibition of 
inflammation.
AbstrAct
Background ankylosing spondylitis (aS) is a complex 
chronic inflammatory disease strongly associated with 
the majority of human leucocyte antigen (Hla)-B27 
alleles. Hla-e molecules are non-classical  major 
histocompatibility complex (MHc) class i molecules that 
specifically interact with the natural killer receptors nKg2a 
(inhibitory) and nKg2c (activating), and have been recently 
proposed to be involved in aS pathogenesis.‘’
Objective to analyse the expression of Hla-e and 
the cD94/nKg2 pair of receptors in Hla-B27-positive 
patients with aS and healthy controls (Hc) bearing the 
aS-associated B*2705 and the non-aS-associated B*2709 
alleles.
Methods the level of surface expression of Hla-e 
molecules on cD14+ peripheral blood mononuclear cell 
was evaluated in 21 Hla-B*2705 patients with aS, 12 
Hla-B*2705 Hc, 12 Hla-B*2709 Hc and 6 Hla-B27-
negative Hc using the monoclonal antibody MeM-e/08 by 
quantitative cytofluorimetric analysis. the percentage and 
density of expression of Hla-e ligands nKg2a and nKg2c 
were also measured on cD3−cD56+ nK cells.
Results Hla-e expression in cD14+ cells was 
significantly higher in patients with aS (587.0, iQr 
424–830) compared with B*2705 Hc (389, iQr 
251.3–440.5; p=0.0007), B*2709 Hc (294.5, iQr 
209.5–422; p=0.0004) and Hla-B27-negative Hc (380, 
iQr 197.3–515.0; p=0.01). a higher number of nK cells 
expressing nKg2a compared with nKg2c were found in all 
cohorts analysed, as well as a higher cell surface density.
Conclusion the higher surface level of Hla-e molecules 
in patients with aS compared with Hc, concurrently 
with a prevalent expression of nKg2a, suggests that the 
crosstalk between these two molecules might play a role 
in aS pathogenesis, accounting for the previously reported 
association between Hla-e and aS.
InTROduCTIOn
Ankylosing spondylitis (AS) is a chronic 
inflammatory disease which primarily affects 
the spine and is characterised by strong 
genetic association with the human leucocyte 
antigen (HLA)-B27.1 2 The classical function 
of HLA class I molecules would suggest the 
role of microbial, exogenous or self-arthrito-
genic peptides in the context of a canonical 
antigen-presenting cell/T cell interaction.3 4 
The lack of a definite demonstration of this 
model has led to the proposition of several 
alternative hypotheses in order to explain 
the B27 association with AS, including cell 
surface B27 heavy chain dimer interactions 
with receptors (killer-cell immunoglob-
ulin-like receptor (KIR)) on cells of the 
innate immune system and/or T cells5–7 and 
the HLA-B27 misfolding and cellular stress 
response.8–10
In this complex scenario two HLA-B27 
alleles, the B*2706 and -B*2709, differing 
from the ancestral and AS-associated 
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B*2705 allele for five or a single amino acid variation, 
respectively, have been shown not to be associated with 
AS,11 12 and several hypotheses have been proposed to 
explain the different disease association of these B27 
alleles.13 14 AS is a complex disorder in which several 
genes contribute to its development, phenotype and 
severity, including important immune response genes 
such as the endoplasmic reticulum aminopeptidase 1 
and 2 (ERAP1 and ERAP2), as well as receptor genes 
involved in cytokine signalling (interleukin-23 receptor, 
IL23R).15 More recently, researchers have paid attention 
to the role of the innate immunity,16 natural killer (NK) 
cells and several immunoregulatory receptors, as well as 
‘nonclassical’ HLA class Ib molecules including HLA-E, 
as possible players in the pathogenesis of immune-medi-
ated diseases, including AS and psoriatic arthritis.17–19
In this regard, we have previously reported in patients 
with AS from Sardinia a significant increase of the A allele 
for single nucleotide polymorphism rs1264457 coding 
an Arginine (Arg) at the HLA-E functional polymor-
phism Arg107/Gly107.20 21 The HLA-E/β2m complexes are 
generally stabilised by peptides derived from the leader 
sequence of HLA class I molecules22 23 and act as ligands 
for inhibitory (NKG2A/CD94) and activating (NKG2A/
CD94) receptors expressed by NK cells.24 25
The aim of this study is therefore to advance our 
previous studies analysing the cell surface expression 
of the HLA-E molecules and the inhibitory/activating 
CD94/NKG2 pair of receptors comparing patients 
with AS with healthy controls (HC) and pathological 
controls.
MeTHOds
Patients and controls 
Twenty-one HLA-B*2705 patients with AS fulfilling the 
modified New York criteria for the diagnosis of AS (15 
men and 6 women, mean age 41.4±8.8, mean disease 
duration 15.7±11.3), 12 HLA-B*2705, 12 HLA-B*2709 
and 6 HLA-B27-negative age-matched and sex-matched 
HCs were recruited. All patients were not on biological 
drug treatment. No case of spondyloarthropathies was 
reported in the family medical history of the HC. As 
further control groups, we also recruited six patients 
with rheumatoid arthritis (RA) and four  HLA-B27-nega-
tive patients with AS.
Reagents and monoclonal antibodies 
For dual and three-colour staining, the following mono-
clonal antibodies were used: Phycoerythrin-conjugated 
anti-CD56 (NKH-1), Phycoerythrin-Texas Red-conju-
gated anti-CD3 (UCHT1) and anti-NKG2A unconjugated 
(Z199), all purchased from Beckman Coulter (Fullerton, 
California), anti-NKG2C unconjugated (clone 134522; 
R&D), PE-anti-CD14 (clone HCD14; BioLegend) 
and fluorescein isothiocyanate (FITC)-conjugated goat 
F(ab')2 antimouse (GAM) IgG (F0479; Dako). For the 
detection of HLA-E surface molecules, three different 
unconjugated monoclonal antibodies were tested: 
MEM-E/06, MEM-E/07 and MEM-E/08 (kindly provided 
by Vaclav Horejsi), recognising surface HLA-E mole-
cules, whose HLA-E specificity was previously defined by 
flow cytometry on the Third International Conference 
on HLA-G (Paris, July 2003).26 27 According to the liter-
ature, MEM-E/08 resulted as the better one in terms 
of specificity and was selected for further experiments. 
The surface expression of HLA-B27 was also analysed 
(by means of clone ME1) to exclude cross-reactivity of 
MEM-E/08 with HLA-B27. The expression of the two 
antigens on cell surface did not overlap. In order to 
avoid possible unspecific staining, as described in table 
1 in Lo Monaco et al,2727 patients and controls were not 
HLA-A24-positive, HLA-B7-positive, HLA-B54-positive or 
HLA-B65-positive.
Isolation of peripheral blood mononuclear cells 
Peripheral blood was collected by venipuncture into 
heparinised tubes, and the mononuclear cells (PBMC) 
were separated by density gradient centrifugation (1250 
g for 20 min) over Ficoll-Hypaque (Sentinel Diagnostics) 
at 20°C. The PBMC-rich interface was collected, washed 
and suspended in tissue culture medium and immedi-
ately stained.
Immunofluorescence staining and cytofluorimetric analysis
The cell surface expression of HLA-E molecules on 
CD14+ and NKG2A or NKG2C ligands on CD3−CD56+ 
NK cells was measured by indirect immunofluorescence 
staining.
Briefly, mononuclear cells were suspended at 5×106 
cells/mL in PBS-NaN3 with 0.2% bovine serum albumin 
(BSA). The entire procedure was performed on ice at 
4°C, and 100 µL (5×105 PBMC) was placed in the analysis 
tube. Fc receptors were blocked by incubating with 10 
µL of normal human serum diluted 1:5 with PBS/BSA. 
PBMCs were then incubated for 30 min with the appro-
priate amount of a saturating concentration of uncon-
jugated primary monoclonal antibody (mAb). After two 
washes cells and mouse IgG-coated quantitative calibra-
tion beads were incubated for 30 min with saturating 
concentration (8 µL/100 µL/tube) of FITC-conjugated 
polyclonal goat antimouse immunoglobulin (FITC-GAM; 
Dako). Cells were then treated with mouse serum 
(Zymed), followed by staining with anti-CD14 or a combi-
nation of anti-CD3 and anti-CD56. PBMCs were washed 
twice, fixed in 500 µL of PBS-1% NaN3 with 1% para-
formaldehyde and analysed by flow cytometry (Coulter 
EPICS XL) within 24 hours (at least 100 000 cells were 
acquired). Controls were always included in the experi-
ments by staining PBMCs with irrelevant mAbs.
Cytofluorimetric analysis was performed using a 
Coulter EPICS XL (Coulter, USA), except for patients 
with RA, HLA-B27-negative patients with AS and culture 
experiments which were performed in a later stage using 
a BD FACSCanto (Becton Dickinson, USA). For each 
sample the mean fluorescence channel was expressed as 
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a relative channel number on a linear scale, compared 
with five differently defined mouse antibodies-coated 
standards (beads) and converted in antibody binding 
capacity (ABC) (Dako, Denmark). The primary and 
secondary antibodies for cells labelling were used at satu-
rating concentration.
Cell culture 
PBMCs were obtained from fresh heparinised blood 
by centrifugation over Ficoll-Hypaque as previously 
described, in four patients with AS. Cells were suspended 
at a final concentration of 1×106 cells/mL and seeded in 
a multiwell plate with RPMI 1640 (Corning) with 10% 
fetal bovine serum (FBS), penicillin-streptomicin and 
glutamine (Corning). Phytohemagglutinin-M (PHA, 
Roche) was used as stimuli at 5 mg/mL concentration. 
Seventy-two hours after seeding, mononuclear cells were 
collected and analysed using the previously described 
cytofluorimetric protocol. The surface expression of 
HLA-E molecules on CD14+ cell was measured using the 
antibodies MEM-08. The T lymphocyte activation induced 
by PHA was verified by means of the IL-2 receptor CD25 
(eBioscience, data not shown).
Calculation of antigen density 
ABC is the number of primary mouse monoclonal anti-
bodies per cell or microbead. Background antibody equiv-
alent (BAE) is the apparent ABC of the negative control 
for cells or blank beads due to background fluorescence. 
Specific antibody binding capacity (SABC) is the number 
of primary mouse monoclonal antibodies per cell after 
corrections for background (BAE): SABC=ABC–BAE. 
Given the saturating conditions of the mAbs, SABC corre-
sponds to the mean number of accessible antigenic sites 
per cell, referred to as antigen density and expressed in 
sites/cell (according to Dako manufacturer’s instruc-
tions).
statistical analysis 
Values were expressed as median percentage of positive 
cells (IQR) and as median of cell surface antigen density 
in ABC units (IQR); the values were also expressed as 
mean±SD. The differences between AS and HC cohorts 
were analysed by one-way  analyses of variance with 
Bonferroni post-test and the two-tailed unpaired t-test 
with Welch’s correction. Statistical analysis was performed 
using Prism V.5.0 software (GraphPad).
ResulTs
HlA-e
HLA-E expression was evaluated by using MEM-E/08 on 
myeloid lineage cells (CD14+) from HLA-B*2705-posi-
tive patients with AS, HLA-B*2705 and HLA-B*2709-pos-
itive HC or HLA-B27-negative HC. We observed a statis-
tically significant higher expression of HLA-E molecules 
on the cell surface of the AS group compared with 
the HC: AS, 587.0 (IQR 268–830, mean 679.7±333.6; 
ABC units); B*2705 HC, 389  (IQR 251.3–440.5, mean 
369.4±123.3; p=0.007); B*2709, 294.5 (IQR 209.5–422, 
mean 336.3±157.9; p=0.0004); and B27-negative HC, 380 
(IQR 197.3–515, mean 373.5±184.1; p=0.01) (figure 1). 
No statistical difference was found between HLA-B*2705, 
HLA-B*2709 and HLA-B27-negative HC (p=ns). 
MEM-E/08 expression was analysed also in CD14− cells: 
AS, 218  (IQR 159.5–310.5, mean 253.2±157.4, ABC 
units); B*2705, 182 (IQR 141.3–325, mean 245.4±164; 
p=ns); B*2709, 180 (IQR 100.5–262.8, mean 189.8±101.3; 
p=ns); and B27-negative HC, 159  (IQR 122.8–235.8, 
mean 179±76.8; p=ns) (see also online supplementary 
figure 1).
HLA-E expression was not correlated with HLA-B27 
expression (determined by means of mAb ME1) in 
patients with AS and HC (r=0.22 ; p=ns) (online supple-
mentary figure 2).
At a later stage, as further control groups, HLA-E mole-
cule expression was also measured in six patients with RA 
(as a different chronic inflammatory arthropathy) and 
four HLA-B27-negative patients and compared with 
B27-positive AS; no statistical differences were observed 
comparing the three pathological groups: RA 537 (IQR 
270.8–612; 488±266; p=ns), B27-negative AS 435 (IQR 
297.3–1201; 644.5±541.2; p=ns).
HLA-E expression was evaluated in CD14+ PBMC 
from four patients with AS following 72 hours in vitro 
culture with medium only or with PHA-M as stimuli, as 
described in the Methods section: 72 hours RPMI 1640-
only 913.5±202.5; PHA 1309.5±554.5, showing a 1.5-fold 
increase following in vitro PHA cell stimulation.
nKG2A
The percentage of NK cells expressing NKG2A in AS 
was 45.8% (IQR 33.5–59.5, 45.6±17.1), in B*2705 HC 
was 38.0% (IQR 30.0–54.8, 39.9±15.0 (AS vs B*2705 
HC;  p=ns)), in B*2709 HC was 45.9% (IQR 35.1–52.9, 
45.1±14.1 (AS vs B*2709 HC;  p=ns)) and in B27-negative 
HC was 44.5% (IQR 28.8–52.0, 41.9±11.2 (AS vs B27-neg-
ative HC;  p=ns)); the surface density of the receptor in 
patients with AS was 7128 ABC units (IQR 6432–8238, 
7443±1497), in B*2705 HC was 8310 ABC units (IQR 
6782–9094, 7784±2046 (AS vs B*2705 HC;  p=ns)), 
in B*2709 HC was 6654 ABC units (IQR 8829–4791, 
6739±841 (AS vs B*2709 HC;  p=ns)) and in B27-negative 
HC was 7505 ABC units (IQR 5937–9265, 7997±2674 (AS 
vs B27-negative HC; p=ns)) (figure 2, upper and lower 
panels). A representative cytofluorographic profile of a 
B27-positive patient with AS showing NKG2A staining on 
CD3−/CD56+ gated PBMC is shown in figure 3A.
nKG2C
Significantly lower percentage of positive NK cells for 
the activating receptor NKG2C was found among AS and 
healthy subjects comparing with the inhibitory receptor 
NKG2A in the same group of subjects:  AS 8.5% (IQR 
6.3–16.7, 14.3±12.1; p<0.0001); B*2705 HC 8.0% (IQR 
4.8–12.9, 11.5±10.9; p=0.0001); B*2709 HC 7.5% (IQR 
6.6–15.9, 11.9±9.6; p<0001); and B27-negative HC 
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Figure 1  (A) HLA-E expression on the surface of CD14+ cells in patients with AS, HLA-B*2705, HLA-B*2709-positive 
and HLA-B27-negative HCs. Results are expressed in specific ABC units. Horizontal lines represent median values. 
Statistical significance was observed only in the comparison between the AS group and the HC group (p<0.001=***0.001 
to 0.01=**0.01 to 0.05=*). No differences were observed among the HC group. (B) Representative cytofluorographic profile 
of a B27-positive patient with AS showing CD14 gating and MEM-E/08 staining in PBMC. ABC, antibody binding capacity; 
AS,  ankylosing spondylitis; FITC,  fluorescein isothiocyanate; HC, healthy control; HLA,  human leucocyte antigen; PBMC, 
peripheral blood mononuclear cell; PE, phycoerythrin; SS, side scatter. 
14.4% (IQR 9.7–21.1, 15.4±7.6; p<0001) (figure 2, upper 
panel). Similarly, NKG2C also showed a lower cell surface 
density compared with the inhibitory receptor, reaching 
statistical significance in patients with AS (p=0.02) and 
B*2705 HCs (p=0.007) (figure 2, lower panel). Analysis 
among groups showed similar density of the activator 
receptor NKG2C on the cell surface in patients with AS 
(4200, IQR 2898–5387, 4992±2998 ABC units; p=ns), in 
B*2705 (4724, IQR 3930–6334, 5339±1922; p=ns), B*2709 
(4633, IQR 3855–7518, 5459±2364; p=ns) and B27-neg-
ative HC (4943 ABC units IQR 3801–6978, 5394±2099; 
p=ns). A representative cytofluorographic profile of a 
B27-positive patient with AS showing NKG2C staining on 
CD3−/CD56+ gated PBMC is shown in figure 3B.
NKG2A and NKG2C percentages of positive cells and 
surface density were also correlated with HLA-E (r=0.11 
and r=−0.02, respectively, for NKG2A; and r=0.02 and 
r=−019, respectively, for NKG2C) and HLA-B27 (r=0.03 
and r=0.11 for NKG2A; and r=−0.14 and r=−0.27 for 
NKG2C) expression. No statistical significance was 
observed in all these analyses.
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Figure 2  (A) NKG2A and (B) NKG2C expression on NK cells in subjects with AS and HCs. The upper figure represents 
% of NK positive cells; the lower figure represents cell surface density of receptor expression (ABC units). Horizontal lines 
represent the median values. Statistical differences were observed between NKG2A and NKG2C percentages of positive 
cells in all different cohorts (upper panel). The inhibitory receptor NKG2A also showed a higher cell surface density compared 
with the activator receptor NKG2C, reaching statistical significance in patients with AS (p=0.02) and B*2705 HCs (p=0.007) 
(lower panel). No differences were observed comparing the different cohorts of subjects. p<0.001=***0.001 to 0.01=**0.01 to 
0.05=* . ABC, antibody binding capacity; AS,  ankylosing spondylitis; HC, healthy control; NK, natural killer.
dIsCussIOn
HLA-E belongs to the non-classical HLA class Ib family 
and is characterised by a limited polymorphism and a 
restricted pattern of cellular expression.18 28 The interac-
tion between HLA-E cell surface molecules and the inhib-
itory (CD94/NKG2A) and activating (CD94/NKG2C) 
receptors is considered to play a crucial role in balancing 
the immunological response involving NK cells and cyto-
toxic T lymphocytes, therefore playing a double role in 
both innate and adaptive immunity.19
The expression of HLA-E mRNA is detectable in 
almost all nucleated cells, while the surface molecular 
expression is more restricted and requires the binding 
of peptides derived from the leader peptide of HLA class 
I molecules to be presented to NK cells. Cells with low 
levels of HLA class I expression generate low levels of 
HLA class I-derived peptides and consequently display 
low levels of HLA-E, thus becoming a better target for the 
NK cells. Conversely, a more abundant level of HLA class 
I molecules can inhibit NK cell lysis, by more effectively 
interacting with the inhibitory receptor CD94/NKG2A.24 
This overexpression could therefore play an indirect role 
by strengthening HLA-E/NKG2A ligation. HLA-E can 
also bind NKG2C activating receptor, although its affinity 
is sixfold lower compared with NKG2A.29
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Figure 3  Representative cytofluorographic profile of a B27-positive patient with AS showing (A) NKG2A and (B) NKG2C 
staining on CD3−/CD56+ gated PBMC. The mean intensity of fluorescence was calculated and transformed in ABC units 
according to calibration beads performed in each experimental session, as described in the Methods section. ECD, 
PhycoerythrinTexasRed-X; FITC,  fluorescein isothiocyanate; FS, forward scatter; NK, natural killer; PBMC, peripheral 
blood mononuclear cell; PE, phycoerythrin; SS, side scatter.
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In two different genetic studies we have previously 
demonstrated a link between HLA-E and AS, and the 
data shown in this study further support the evidence 
of a role in the complex mechanisms which drive the 
inflammatory milieu in AS. HLA-E is also involved in 
viral, cancer and multiple sclerosis immunity,30 and we 
therefore cannot currently exclude that other mecha-
nisms may also explain its association with AS. It is never-
theless intriguing that HLA-E has been reported to be 
upregulated in peripheral blood and synovial fluid cells 
from patients with juvenile idiopathic arthritis,31 and 
in this regard we also found in patients with RA a high 
level of HLA-E expression, similar to AS. It has been also 
demonstrated that HLA-E and its homologue in mice are 
able to inhibit NK cells cytolysis.32 Furthermore, blocking 
HLA-E/NKG2A interaction by means of monoclonal anti-
bodies in a mouse model of encephalomyelitis resulted 
in amelioration of the disease because of NK-dependent 
lysis of autoreactive cells.33 Taken together these data 
may suggest that upregulation of HLA-E in AS immune 
cells may protect autoreactive clones from NK cell lysis 
and therefore contribute to the chronicity of the inflam-
matory process, while the inflammatory milieu may itself 
upregulate HLA-E expression, as suggested by our in 
vitro data showing increased expression of HLA-E mole-
cules following PBMC stimulation with PHA.
The data emerging from this study confirm that innate 
immunity and NK cells may play a relevant role in the 
pathogenesis of AS and that HLA-E may provide a contri-
bution to the leading role played by HLA-B27 as well as 
environmental factors.34 35 A large spectrum of ligands 
and receptors contribute to orchestrate NK functions 
that are further fine-tuned by different pairs of ligands 
and receptors. In the Sardinian population, we have 
previously shown an association of HLA-E with AS. This 
association might be present in some populations but not 
in others. In this regard, it is noteworthy that two studies 
from Spain and Asia36 37 have described an imbalance 
of KIR alleles in patients with AS, but these data could 
not be confirmed in a cohort from UK.38 The possible 
discrepancy in accessory pathways in different popula-
tions may be explained by different genetic background 
and environmental pressure, which may lead to impaired 
regulatory functions. For the above-mentioned reasons, 
genetic isolate as the Sardinian population13 appears to 
be the ideal cohort to single out predisposing genes in 
complex diseases, particularly in pathological conditions 
like AS where a single gene (HLA-B27) accounts for most 
of the genetic predisposition.
COnClusIOn
This study shows a higher expression of HLA-E mole-
cules in patients with AS compared with HC and a larger 
expansion of NK cells expressing the NKG2A inhibitory 
receptor, which also appears more expressed on the cell 
surface. Taken together, the data suggest that the cross-
talk between the HLA-E molecules and the corresponding 
inhibitory receptors on the NK cells might play a role in 
AS pathogenesis, accounting for the previously reported 
association between HLA-E and AS in Sardinia.
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